Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. - Weller, M.; Weber, R. G.; Willscher, E.; Riehmer, V.; Hentschel, B.; Kreuz, M.; Felsberg, J.; Beyer, U.; Loffler-Wirth, H.; Kaulich, K.; Steinbach, J. P.; Hartmann, C.; et al. (Acta Neuropathol, 2015)